Exploring Current ME/CFS and Long COVID Clinical Trials on National Clinical Trials Day
May 20 is National Clinical Trials Day! When conducting clinical trials, researchers test how interventions (like behavioral changes, drugs, or medical devices) affect people. Usually, researchers carefully choose who takes […]
Hope Amid Uncertainty
A special message from Solve M.E. President and CEO Emily Taylor With so much speculation about the future, it’s easy to feel unsettled – and uncertainty is especially hard for […]
An Evolving Landscape: Long Covid’s Impact on ME/CFS
It’s hard to believe that we’re well into the third year of the COVID-19 pandemic, which coincidentally overlaps with my time as Solve M.E.’s President and CEO. In this time […]
Breaking News: FDA clears Ampligen to start a clinical trial in Long Covid
A decade after the U.S. Food and Drug Administration (FDA) did not approve Ampligen (rintatolimod) for the treatment of ME/CFS, this antiviral and immuno-modulator drug is getting a rare second chance. […]
AIM ImmunoTech Announces Update on Ampligen Long Covid Development Program
Today, AIM ImmunoTech, an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, provided an update […]
Ampligen: A General Overview and the Plan for ME/CFS & Long Covid
For the second installment in our clinical diagnostics and treatments webinar series, Solve M.E. welcomes two leaders from bio-pharma company AIM ImmunoTech to discuss their plans for clinical studies of […]